SCHEMBL4744679

SCHEMBL4744679

Clc1ccnc2ccc(Oc3ccccc3)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 1/20 0.49
ACHE P22303 5/20 0.45
BCHE P06276 4/20 0.45
PDGFRB P09619 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
LTA4H P09960 2/20 0.41
LMNA P02545 1/20 0.40
EGFR P00533 1/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPK1 P28482 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4748546 0.81 ERBB2 (0.49) ERBB2ACHEBCHEPDGFRBL3MBTL1
SCHEMBL10251583 0.81 NCF1 (0.53) ERBB2ACHEBCHEL3MBTL1MAPT
SCHEMBL3899573 0.80 IP6K1 (0.56) ERBB2NPC1RAB9AEGFRHPGD
SCHEMBL30827905 0.79 ACHE (0.49) ACHEBCHEL3MBTL1MAPTTDP1
SCHEMBL4745132 0.79 ACHE (0.49) ACHEBCHEL3MBTL1MAPTTDP1
SCHEMBL282245 0.78 LMNA (0.58) MAPTLMNAKDM4EMAPK1CYP1A2
SCHEMBL29729443 0.78 LMNA (0.58) MAPTLMNAKDM4EMAPK1CYP1A2
SCHEMBL32684711 0.77 LMNA (0.69) ERBB2PDGFRBSMN1; SMN2LMNAKDM4E
SCHEMBL3647767 0.76 MAPT (0.61) ACHEBCHEL3MBTL1MAPTTDP1
SCHEMBL31121065 0.75 PIK3CA (0.59) L3MBTL1MAPTDYRK1BEGFRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008117079-A1 ANTIMICROBIAL COMPOUNDS BASED UPON 4-AMINOQUINOLINE HELPERBY THERAPEUTICS LIMITED (GB) 2008-10-02 WO disclosed